 Dejene Tufa
Concepts (85)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dendritic Cells | 3 | 2016 | 442 | 1.290 |
Why?
| | Hematopoietic Stem Cells | 3 | 2020 | 359 | 1.160 |
Why?
| | Killer Cells, Natural | 4 | 2020 | 381 | 1.110 |
Why?
| | Interleukin-1beta | 2 | 2016 | 379 | 0.950 |
Why?
| | Receptors, Prolactin | 1 | 2020 | 9 | 0.750 |
Why?
| | Lymphopoiesis | 1 | 2020 | 23 | 0.740 |
Why?
| | Smad7 Protein | 1 | 2020 | 26 | 0.740 |
Why?
| | Prolactin | 1 | 2020 | 96 | 0.730 |
Why?
| | GATA3 Transcription Factor | 1 | 2019 | 26 | 0.680 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2020 | 164 | 0.680 |
Why?
| | T-Lymphocytes, Helper-Inducer | 1 | 2019 | 130 | 0.650 |
Why?
| | Cell Differentiation | 4 | 2022 | 1753 | 0.570 |
Why?
| | fas Receptor | 1 | 2016 | 98 | 0.550 |
Why?
| | Receptors, Tumor Necrosis Factor, Type II | 1 | 2014 | 36 | 0.510 |
Why?
| | Interleukin-12 | 1 | 2014 | 110 | 0.490 |
Why?
| | Immunity, Innate | 1 | 2019 | 745 | 0.450 |
Why?
| | Gene Expression Regulation | 2 | 2019 | 2445 | 0.420 |
Why?
| | Cell Membrane | 1 | 2014 | 710 | 0.380 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2014 | 1171 | 0.350 |
Why?
| | Pluripotent Stem Cells | 2 | 2022 | 65 | 0.350 |
Why?
| | Hematopoiesis | 2 | 2020 | 175 | 0.310 |
Why?
| | Amino Sugars | 2 | 2016 | 8 | 0.270 |
Why?
| | Inflammation | 1 | 2016 | 2566 | 0.260 |
Why?
| | Cell Communication | 3 | 2016 | 281 | 0.260 |
Why?
| | Dinoprostone | 2 | 2016 | 193 | 0.250 |
Why?
| | Antigens, CD34 | 2 | 2022 | 98 | 0.240 |
Why?
| | Hemangioblasts | 1 | 2022 | 3 | 0.220 |
Why?
| | HIV Infections | 1 | 2016 | 2459 | 0.210 |
Why?
| | Heterografts | 1 | 2021 | 130 | 0.190 |
Why?
| | Myeloid Progenitor Cells | 1 | 2020 | 16 | 0.190 |
Why?
| | CD56 Antigen | 1 | 2020 | 34 | 0.190 |
Why?
| | fms-Like Tyrosine Kinase 3 | 1 | 2020 | 42 | 0.180 |
Why?
| | Hematopoietic Stem Cell Transplantation | 2 | 2022 | 540 | 0.180 |
Why?
| | Immune System | 1 | 2021 | 181 | 0.180 |
Why?
| | Lymphocytes | 1 | 2020 | 347 | 0.160 |
Why?
| | Cell Lineage | 1 | 2020 | 318 | 0.160 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2017 | 36 | 0.150 |
Why?
| | Cells, Cultured | 4 | 2022 | 4077 | 0.150 |
Why?
| | Immunotherapy | 1 | 2021 | 493 | 0.150 |
Why?
| | Fas Ligand Protein | 1 | 2016 | 60 | 0.140 |
Why?
| | CD4 Lymphocyte Count | 1 | 2016 | 267 | 0.140 |
Why?
| | Coculture Techniques | 1 | 2016 | 208 | 0.130 |
Why?
| | Cyclooxygenase 2 | 1 | 2016 | 168 | 0.130 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2020 | 814 | 0.130 |
Why?
| | Viral Load | 1 | 2016 | 419 | 0.130 |
Why?
| | Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2014 | 143 | 0.120 |
Why?
| | Amyloid Precursor Protein Secretases | 1 | 2014 | 76 | 0.120 |
Why?
| | Adenosine | 1 | 2014 | 211 | 0.110 |
Why?
| | Lymphocyte Activation | 1 | 2016 | 1067 | 0.110 |
Why?
| | Immune Tolerance | 1 | 2014 | 334 | 0.100 |
Why?
| | Disease Models, Animal | 1 | 2021 | 3730 | 0.100 |
Why?
| | Up-Regulation | 1 | 2014 | 872 | 0.100 |
Why?
| | Humans | 9 | 2021 | 118972 | 0.100 |
Why?
| | Lipopolysaccharides | 1 | 2014 | 870 | 0.100 |
Why?
| | HIV-1 | 1 | 2016 | 776 | 0.100 |
Why?
| | NF-kappa B | 1 | 2014 | 670 | 0.090 |
Why?
| | Lymphocyte Subsets | 2 | 2021 | 76 | 0.090 |
Why?
| | Case-Control Studies | 1 | 2016 | 3171 | 0.080 |
Why?
| | B-Lymphocytes | 1 | 2014 | 770 | 0.080 |
Why?
| | Neoplasms | 1 | 2021 | 2179 | 0.070 |
Why?
| | Apoptosis | 1 | 2016 | 2484 | 0.070 |
Why?
| | T-Lymphocytes | 1 | 2014 | 1774 | 0.070 |
Why?
| | Signal Transduction | 1 | 2014 | 4709 | 0.050 |
Why?
| | Chimerism | 1 | 2021 | 28 | 0.050 |
Why?
| | Lymphoid Tissue | 1 | 2021 | 65 | 0.050 |
Why?
| | Histone Deacetylase Inhibitors | 1 | 2022 | 200 | 0.050 |
Why?
| | Mice, SCID | 1 | 2021 | 333 | 0.050 |
Why?
| | Phenotype | 2 | 2021 | 3003 | 0.050 |
Why?
| | Male | 2 | 2016 | 57801 | 0.040 |
Why?
| | Mice, Inbred NOD | 1 | 2021 | 574 | 0.040 |
Why?
| | Female | 2 | 2016 | 61564 | 0.040 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2021 | 740 | 0.040 |
Why?
| | Embryonic Stem Cells | 1 | 2017 | 114 | 0.040 |
Why?
| | Middle Aged | 1 | 2016 | 27617 | 0.030 |
Why?
| | Mice | 2 | 2022 | 15520 | 0.030 |
Why?
| | Cytotoxicity Tests, Immunologic | 1 | 2014 | 49 | 0.030 |
Why?
| | Cell Degranulation | 1 | 2014 | 38 | 0.030 |
Why?
| | Adult | 1 | 2016 | 31512 | 0.030 |
Why?
| | K562 Cells | 1 | 2014 | 73 | 0.030 |
Why?
| | Mice, Knockout | 1 | 2021 | 2680 | 0.030 |
Why?
| | Umbilical Cord | 1 | 2014 | 84 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 2014 | 228 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2014 | 980 | 0.020 |
Why?
| | Animals | 2 | 2022 | 33381 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2014 | 5255 | 0.010 |
Why?
|
|
Tufa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|